Please use this identifier to cite or link to this item: 10.1097/j.jcrs.0000000000000640
Title: Selective transepithelial ablation with simultaneous accelerated corneal crosslinking for corneal regularization of keratoconus : STARE-X protocol
Authors: Rechichi, Miguel
Mazzotta, Cosimo
Oliverio, Giovanni William
Romano, Vito
Borroni, Davide
Ferrise, Marco
Bagaglia, Simone
Jacob, Soosan
Meduri, Alessandro
Department of Ophthalmology
Keywords: 3.2 Clinical medicine;1.1. Scientific article indexed in Web of Science and/or Scopus database;Surgery;Ophthalmology;Sensory Systems
Issue Date: 1-Nov-2021
Citation: Rechichi , M , Mazzotta , C , Oliverio , G W , Romano , V , Borroni , D , Ferrise , M , Bagaglia , S , Jacob , S & Meduri , A 2021 , ' Selective transepithelial ablation with simultaneous accelerated corneal crosslinking for corneal regularization of keratoconus : STARE-X protocol ' , Journal of Cataract and Refractive Surgery , vol. 47 , no. 11 , pp. 1403-1410 . https://doi.org/10.1097/j.jcrs.0000000000000640
Abstract: PURPOSE: To evaluate the changes in refractive outcomes and corneal aberrations in central and paracentral keratoconus after selective transepithelial topography-guided photorefractive keratectomy combined with accelerated corneal crosslinking (STARE-X). SETTINGS: Centro Polispecialistico Mediterraneo, Siena Crosslinking Center, and University of Messina, Italy. DESIGN: Prospective, interventional, multicentric study. METHODS: Patients were subdivided into 2 groups: Group 1 with cone located within the central 3 mm zone (50 eyes) and Group 2 (50 eyes) with cone located outside the central 3 mm zone. Follow-up was 2 years at least for all eyes. Outcome parameters included uncorrected distance visual acuity (UDVA) and corrected distance visual acuity (CDVA). Corneal tomography and corneal wavefront aberrations were assessed and compared before and 2 years after the treatment. RESULTS: 100 eyes of 100 patients underwent STARE-X protocol. At 2 years, UDVA and CDVA improved, and sphere, cylinder, and Kmax reduced after treatment in both groups (P < .001, respectively). Moreover, a statistically significant reduction was observed of total higher-order aberrations root main square (RMS), coma RMS, and spherical aberration RMS in both groups (P < .001, respectively). However, CDVA improved more in Group 1 than in Group 2 (P < .02). CONCLUSIONS: The STARE-X protocol demonstrated effective results in halting keratoconus progression and improving corneal regularity with a safe and effective profile. STARE-X improved both visual acuity and corneal aberration at 2 years. Longer follow-up studies are warranted to observe further long-term CXL flattening effect on the cone.
Description: Publisher Copyright: Copyright © 2021 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of ASCRS and ESCRS.
DOI: 10.1097/j.jcrs.0000000000000640
ISSN: 0886-3350
Appears in Collections:Research outputs from Pure / Zinātniskās darbības rezultāti no ZDIS Pure

Files in This Item:
File SizeFormat 
Selective_transepithelial_ablation_with.pdf651.03 kBAdobe PDFView/Openopen_acces_unlocked


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.